Wednesday, April 15, 2015
Columbus-based healthcare startup CrossChx announced today that it has raised $15 million in Series B funding.
Led by Khosla Ventures and investor Drive Capital, this round brings CrossChx’s total funding to more than $20 million, according to a release. Keith Rabois, a partner at Khosla Ventures, will be an observer on the startup's board.
Drive Capital, co-founded by tech-capitalist Mark Kvamme, chose CrossChx as one of its first investments in 2013. The company deals in “global patient identification,” making patient information more secure by creating a unique code for each person.
“One of the most pressing issues in healthcare today is verifying and protecting patient identity,” Sean Lane, CEO and co-founder of CrossChx, said in the release. “Our goal is not only to provide more accurate and potentially life-saving information to medical personnel, but also to safeguard patients against fraud and abuse, and empower them with control over their medical records. We believe that a global patient identity is not only achievable but a fundamental necessity for healthcare.”
CrossChx plans to continue its national expasion and create a mobile platform in the coming months. The firm is currently working with more than 100 hospitals across eight states.
columbusceo.com
